In vitro assessment of cobalt oxide particle toxicity: Identifying and circumventing interference

Toxicology in Vitro

Volumn 27, Issue 6, 2013, Pages 1699-1710

  Darolles, Carine ^a   Sage, Nicole ^a   Armengaud, Jean ^a   Malard, Véronique ^a  

^a DIF   (France)

Author keywords

Cobalt; In vitro methods; Interference; Particles; Toxicity; Viability assays

Indexed keywords

COBALT DERIVATIVE; COBALT OXIDE; NANOPARTICLE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; NANOTECHNOLOGY; RELIABILITY; TOXICITY TESTING;

COBALT; IN VITRO METHODS; INTERFERENCE; PARTICLES; TOXICITY; VIABILITY ASSAYS;

ADENOSINE TRIPHOSPHATE; BIOLOGICAL ASSAY; CELL CYCLE; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; COBALT; HUMANS; METAL NANOPARTICLES; MICROSCOPY, ELECTRON, SCANNING; OXIDES; PARTICLE SIZE; TOXICITY TESTS;

EID: 84878362080     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2013.04.008     Document Type: Article

References (59)

1. Aam B.B., Fonnum F. Carbon black particles increase reactive oxygen species formation in rat alveolar macrophages in vitro. Arch. Toxicol. 2007, 81:441-446.
2. Alarifi S., Ali D., Y A.O., Ahamed M., Siddiqui M.A., Al-Khedhairy A.A. Oxidative stress contributes to cobalt oxide nanoparticles-induced cytotoxicity and DNA damage in human hepatocarcinoma cells. Int. J. Nanomed. 2013, 8:17-23.
3. ATSDR, 2004. Toxicological Profile for Cobalt. Agency for Toxic Substances and Disease Registry. U.S. Department of Health and Human Services http://www.atsdr.cdc.gov.
4. Barceloux D.G. Cobalt. J. Toxicol. Clin. Toxicol. 1999, 37:201-206.
5. Bouchard L.S., Anwar M.S., Liu G.L., Hann B., Xie Z.H., Gray J.W., Wang X., Pines A., Chen F.F. Picomolar sensitivity MRI and photoacoustic imaging of cobalt nanoparticles. Proc. Natl. Acad. Sci. USA 2009, 106:4085-4089.
6. Brown J.M., Attardi L.D. Opinion - the role of apoptosis in cancer development and treatment response. Nat. Rev. Cancer 2005, 5:231-237.
7. Bruick R.K. Oxygen sensing in the hypoxic response pathway: regulation of the hypoxia-inducible transcription factor. Genes Dev. 2003, 17:2614-2623.
8. Brunauer S., Emmett P.H., Teller E. Adsorption of gases in multimolecular layers. J. Am. Chem. Soc. 1938, 60:309.
9. Casey A., Herzog E., Davoren M., Lyng F.M., Byrne H.J., Chambers G. Spectroscopic analysis confirms the interactions between single walled carbon nanotubes and various dyes commonly used to assess cytotoxicity. Carbon 2007, 45:1425-1432.
10. Davis K., Marsh J.W., Gerondal M., Bailey M.R., Le Guen B. Assessment of intakes and doses to workers followed for 15years after accidental inhalation of 60CO. Health Phys. 2007, 92:332-344.
11. Davoren M., Herzog E., Casey A., Cottineau B., Chambers G., Byrne H.J., Lyng F.M. In vitro toxicity evaluation of single walled carbon nanotubes on human A549 lung cells. Toxicol. In Vitro 2007, 21:438-448.
12. De Boeck M., Kirsch-Volders M., Lison D. Cobalt and antimony: genotoxicity and carcinogenicity. Mutat. Res. 2003, 533:135-152.
13. Dhawan A., Sharma V. Toxicity assessment of nanomaterials: methods and challenges. Anal. Bioanal. Chem. 2010, 398:589-605.
14. Doak S.H., Griffiths S.M., Manshian B., Singh N., Williams P.M., Brown A.P., Jenkins G.J. Confounding experimental considerations in nanogenotoxicology. Mutagenesis 2009, 24:285-293.
15. Franken N.A., Rodermond H.M., Stap J., Haveman J., van Bree C. Clonogenic assay of cells in vitro. Nat. Protoc. 2006, 1:2315-2319.
16. Herzog E., Casey A., Lyng F.M., Chambers G., Byrne H.J., Davoren M. A new approach to the toxicity testing of carbon-based nanomaterials - the clonogenic assay. Toxicol. Lett. 2007, 174:49-60.
17. Horev-Azaria L., Kirkpatrick C.J., Korenstein R., Marche P.N., Maimon O., Ponti J., Romano R., Rossi F., Golla-Schindler U., Sommer D., Uboldi C., Unger R.E., Villiers C. Predictive toxicology of cobalt nanoparticles and ions: comparative in vitro study of different cellular models using methods of knowledge discovery from data. Toxicol. Sci. 2011, 122:489-501.
18. Hoskins C., Wang L., Cheng W.P., Cuschieri A. Dilemmas in the reliable estimation of the in-vitro cell viability in magnetic nanoparticle engineering: which tests and what protocols?. Nanoscale Res. Lett. 2012, 7:77.
19. IARC, 2006. Cobalt in Hard Metals and Cobalt Sulfate, Gallium Arsenide, Indium Phosphide and Vanadium Pentoxide.
20. Johnston H.J., Hutchison G.R., Christensen F.M., Peters S., Hankin S., Stone V. Identification of the mechanisms that drive the toxicity of TiO(2) particulates: the contribution of physicochemical characteristics. Part Fibre Toxicol. 2009, 6:33.
21. Kroll A., Dierker C., Rommel C., Hahn D., Wohlleben W., Schulze-Isfort C., Gobbert C., Voetz M., Hardinghaus F., Schnekenburger J. Cytotoxicity screening of 23 engineered nanomaterials using a test matrix of ten cell lines and three different assays. Part Fibre Toxicol. 2011, 8:9.
22. Kroll A., Pillukat M.H., Hahn D., Schnekenburger J. Current in vitro methods in nanoparticle risk assessment: limitations and challenges. Eur. J. Pharm. Biopharm. 2009, 72:370-377.
23. Kroll A., Pillukat M.H., Hahn D., Schnekenburger J. Interference of engineered nanoparticles with in vitro toxicity assays. Arch. Toxicol. 2012, 86:1123-1136.
24. Laaksonen T., Santos H., Vihola H., Salonen J., Riikonen J., Heikkila T., Peltonen L., Kumar N., Murzin D.Y., Lehto V.P., Hirvonen J. Failure of MTT as a toxicity testing agent for mesoporous silicon microparticles. Chem. Res. Toxicol. 2007, 20:1913-1918.
25. Lewinski N., Colvin V., Drezek R. Cytotoxicity of nanoparticles. Small 2008, 4:26-49.
26. Limbach L.K., Wick P., Manser P., Grass R.N., Bruinink A., Stark W.J. Exposure of engineered nanoparticles to human lung epithelial cells: influence of chemical composition and catalytic activity on oxidative stress. Environ. Sci. Technol. 2007, 41:4158-4163.
27. Lison D., De Boeck M., Verougstraete V., Kirsch-Volders M. Update on the genotoxicity and carcinogenicity of cobalt compounds. Occup. Environ. Med. 2001, 58:619-625.
28. Malard V., Chardan L., Roussi S., Darolles C., Sage N., Gaillard J.C., Armengaud J. Analytical constraints for the analysis of human cell line secretomes by shotgun proteomics. J. Proteom. 2012, 75:1043-1054.
29. Medina C., Santos-Martinez M.J., Radomski A., Corrigan O.I., Radomski M.W. Nanoparticles: pharmacological and toxicological significance. Br. J. Pharmacol. 2007, 150:552-558.
30. Monteiro-Riviere N.A., Inman A.O. Challenges for assessing carbon nanomaterial toxicity to the skin. Carbon 2006, 44:1070-1078.
31. Monteiro-Riviere N.A., Inman A.O., Zhang L.W. Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol. Appl. Pharmacol. 2009, 234:222-235.
32. Nel A.E., Madler L., Velegol D., Xia T., Hoek E.M., Somasundaran P., Klaessig F., Castranova V., Thompson M. Understanding biophysicochemical interactions at the nano-bio interface. Nat. Mater. 2009, 8:543-557.
33. Panas A., Marquardt C., Nalcaci O., Bockhorn H., Baumann W., Paur H.R., Mulhopt S., Diabate S., Weiss C. Screening of different metal oxide nanoparticles reveals selective toxicity and inflammatory potential of silica nanoparticles in lung epithelial cells and macrophages. Nanotoxicology. 2012, 7:259-273.
34. Papis E., Rossi F., Raspanti M., Dalle-Donne I., Colombo G., Milzani A., Bernardini G., Gornati R. Engineered cobalt oxide nanoparticles readily enter cells. Toxicol. Lett. 2009, 189:253-259.
35. Peters K., Unger R.E., Gatti A.M., Sabbioni E., Tsaryk R., Kirkpatrick C.J. Metallic nanoparticles exhibit paradoxical effects on oxidative stress and pro-inflammatory response in endothelial cells in vitro. Int. J. Immunopathol. Pharmacol. 2007, 20:685-695.
36. Ponti J., Sabbioni E., Munaro B., Broggi F., Marmorato P., Franchini F., Colognato R., Rossi F. Genotoxicity and morphological transformation induced by cobalt nanoparticles and cobalt chloride: an in vitro study in Balb/3T3 mouse fibroblasts. Mutagenesis 2009, 24:439-445.
37. Puck T.T., Marcus P.I. Action of X-rays on mammalian cells. J. Exp. Med. 1956, 103:653-666.
38. Pulido M.D., Parrish A.R. Metal-induced apoptosis: mechanisms. Mutat. Res. 2003, 533:227-241.
39. Puntes V.F., Krishnan K.M., Alivisatos A.P. Colloidal nanocrystal shape and size control: the case of cobalt. Science 2001, 291:2115-2117.
40. Sabatini C.A., Pereira R.V., Gehlen M.H. Fluorescence modulation of acridine and coumarin dyes by silver nanoparticles. J. Fluoresc. 2007, 17:377-382.
41. Salnikow K., Su W., Blagosklonny M.V., Costa M. Carcinogenic metals induce hypoxia-inducible factor-stimulated transcription by reactive oxygen species-independent mechanism. Cancer Res. 2000, 60:3375-3378.
42. Sayes C.M., Reed K.L., Subramoney S., Abrams L., Warheit D.B. Can in vitro assays substitute for in vivo studies in assessing the pulmonary hazards of fine and nanoscale materials?. J. Nanopart. Res. 2009, 11:421-431.
43. Schulze C., Kroll A., Lehr C.M., Schafer U.F., Becker K., Schnekenburger J., Isfort C.S., Landsiedel R., Wohlleben W. Not ready to use - overcoming pitfalls when dispersing nanoparticles in physiological media. Nanotoxicology 2008, 2. 51-U17.
44. Sharma V., Shukla R.K., Saxena N., Parmar D., Das M., Dhawan A. DNA damaging potential of zinc oxide nanoparticles in human epidermal cells. Toxicol. Lett. 2009, 185:211-218.
45. Shaw S.Y., Westly E.C., Pittet M.J., Subramanian A., Schreiber S.L., Weissleder R. Perturbational profiling of nanomaterial biologic activity. Proc. Natl. Acad. Sci. USA 2008, 105:7387-7392.
46. Shih Y.H., Zhuang C.M., Peng Y.H., Lin C.H., Tseng Y.M. The effect of inorganic ions on the aggregation kinetics of lab-made TiO(2) nanoparticles in water. Sci. Total Environ. 2012, 435-436:446-452.
47. Shukla R., Thomas T.P., Peters J.L., Desai A.M., Kukowska-Latallo J., Patri A.K., Kotlyar A., Baker J.R. HER2 specific tumor targeting with dendrimer conjugated anti-HER2 mAb. Bioconjugate Chem. 2006, 17:1109-1115.
48. Simonsen L.O., Harbak H., Bennekou P. Cobalt metabolism and toxicology - a brief update. Sci. Total Environ. 2012, 432:210-215.
49. Singh S., D'Britto V., Prabhune A.A., Ramana C.V., Dhawan A., Prasad B.L.V. Cytotoxic and genotoxic assessment of glycolipid-reduced and -capped gold and silver nanoparticles. New J. Chem. 2010, 34:294-301.
50. Skumryev V., Stoyanov S., Zhang Y., Hadjipanayis G., Givord D., Nogues J. Beating the superparamagnetic limit with exchange bias. Nature 2003, 423:850-853.
51. Song M.M., Song W.J., Bi H., Wang J., Wu W.L., Sun J., Yu M. Cytotoxicity and cellular uptake of iron nanowires. Biomaterials 2010, 31:1509-1517.
52. Stone V., Johnston H., Schins R.P. Development of in vitro systems for nanotoxicology: methodological considerations. Crit. Rev. Toxicol. 2009, 39:613-626.
53. Ulukaya E., Ozdikicioglu F., Oral A.Y., Demirci M. The MTT assay yields a relatively lower result of growth inhibition than the ATP assay depending on the chemotherapeutic drugs tested. Toxicol. In Vitro 2008, 22:232-239.
54. Veranth J.M., Cutler N.S., Kaser E.G., Reilly C.A., Yost G.S. Effects of cell type and culture media on Interleukin-6 secretion in response to environmental particles. Toxicol. In Vitro 2008, 22:498-509.
55. Wahl B., Daum N., Ohrem H.L., Lehr C.M. Novel luminescence assay offers new possibilities for the risk assessment of silica nanoparticles. Nanotoxicology 2008, 2:243-251.
56. Warheit D.B., Sayes C.M., Reed K.L. Nanoscale and fine zinc oxide particles: can in vitro assays accurately forecast lung hazards following inhalation exposures?. Environ. Sci. Technol. 2009, 43:7939-7945.
57. Wilhelmi V., Fischer U., van Berlo D., Schulze-Osthoff K., Schins R.P., Albrecht C. Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: facts and artefacts. Toxicol. In Vitro 2012, 26:323-334.
58. Worle-Knirsch J.M., Pulskamp K., Krug H.F. Oops they did it again! Carbon nanotubes hoax scientists in viability assays. Nano Lett. 2006, 6:1261-1268.
59. 2 nanoparticles induce cytotoxicity and protein expression alteration in HaCaT cells. Part Fibre Toxicol. 2010, 7:1.